To address this, our manuscript aims to elucidate the intricate interplay between GD3S and WT or mutant p53 by employing a comprehensive strategy that analyzes data from BC patients and cell lines through various experimental approaches, aiming to shed light on the mechanistic aspects of their cooperative effects and reveal novel therapeutic vulnerabilities for BC treatment. The gene discussed is TP53; the disease is breast cancer.